Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and immunogenicity of COVID-19 vaccines in lung cancer patients
TCTR20240811003Completed
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Aug 2021
- Countries
- 1
01
Overview
Trial in coronavirus disease 2019 (COVID-19), sponsored by Faculty of Medicine, Chiang Mai University. Primary endpoints: Safety of COVID-19 vaccines and Immunogenicity of COVID-19 vaccines. Started Aug 2021; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20240811003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240811003.